References

Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study

10.3389/fphar.2022.837890 · 2022 · External reference

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease

10.1080/13543784.2017.1371133 · 2017 · External reference

Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson’s disease

10.1002/pds.5176 · 2021 · External reference

Use of calcium channel blockers and Parkinson’s disease

10.1093/aje/kwr362 · 2012 · External reference

In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation

10.1186/s13287-021-02585-2 · 2021 · External reference

The association between developing Parkinson’s disease and beta-Adrenoceptor acting agents use: A systematic review and meta-analysis

10.1016/j.jns.2021.120009 · 2021 · External reference

beta-adrenoreceptors and the risk of Parkinson’s disease

10.1016/s1474-4422(19)30400-4 · 2020 · External reference

Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease

10.1001/jamaneurol.2022.3902 · 2023 · External reference

Hypertension and Diagnosis of Parkinson’s Disease: A Meta-Analysis of Cohort Studies

10.3389/fneur.2018.00162 · 2018 · External reference

Use of antihypertensives and the risk of Parkinson disease

10.1212/01.wnl.0000303818.38960.44 · 2008 · External reference

Basic characteristics and representativeness of the German Disease Analyzer database

10.5414/cp203320 · 2018 · External reference

Association between antihypertensive medication and the risk of urinary tract infection (UTI) of outpatients: a retrospective cohort study

10.1007/s15010-022-01895-8 · 2023 · External reference

Identification of Prodromal Presentations of Parkinson’s Disease among Primary Care Outpatients in Germany

10.1159/000520574 · 2022 · External reference

The association between antihypertensive therapy and the incidence of Parkinson’s disease in patients followed in general practices in Germany

10.5414/cp203559 · 2019 · External reference

Association of Angiotensin Receptor Blockers with Incident Parkinson Disease in Patients with Hypertension: A Retrospective Cohort Study

10.1016/j.amjmed.2022.04.029 · 2022 · External reference

The role of brain vasculature in neurodegenerative disorders

10.1038/s41593-018-0234-x · 2018 · External reference

Calcium Channel blockers are associated with reduced risk of Parkinson’s disease in patients with hypertension: A population-based retrospective cohort study

10.1016/j.jns.2021.117412 · 2021 · External reference